Sediment in the form of crystals was found at the bottom of the syrup bottle, not compliant with the quality specification. Failure to determine the cause of crystallization and the risk of disturbed antimicrobial protection and microbiological purity prevent ruling out a risk to patient health. Potential effects: infections, lack of treatment efficacy, health complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use DEXAPINI syrup from the specified batches; check the batch number on the packaging and, if you have the product, return it to the pharmacy or place of purchase. If any concerning symptoms o...
The DEXAPINI medicinal product batches 02092024 and 01122024 were withdrawn from the market throughout the country, placing these batches on the market was prohibited, and the decision was given immed...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related